$ONVO
ORGANOVO HOLDINGS, INC.

2014 Q1 Form 10-Q Financial Statement

#000119312514038955 Filed on February 06, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $120.0K $135.0K $349.0K
YoY Change -44.19% -61.32% -64.02%
Cost Of Revenue $0.00 $0.00
YoY Change -100.0%
Gross Profit $120.0K $350.0K
YoY Change -44.19% -58.82%
Gross Profit Margin 100.0% 100.29%
Selling, General & Admin $4.250M $2.379M $2.141M
YoY Change 52.22% 11.12% 23.76%
% of Gross Profit 3541.67% 611.71%
Research & Development $2.550M $2.359M $1.130M
YoY Change 76.1% 108.76% -20.42%
% of Gross Profit 2125.0% 322.86%
Depreciation & Amortization $100.0K $100.0K $80.00K
YoY Change 25.0% 25.0%
% of Gross Profit 83.33% 22.86%
Operating Expenses $6.800M $4.738M $3.271M
YoY Change 60.38% 44.85% 3.84%
Operating Profit -$6.680M -$4.626M -$2.922M
YoY Change 65.96% 58.32% 27.04%
Interest Expense $13.00K -$580.0K -$6.640M
YoY Change -80.0% -91.27% 220.77%
% of Operating Profit
Other Income/Expense, Net $0.00 -$582.0K -$6.642M
YoY Change -100.0% -91.24%
Pretax Income -$6.480M -$5.210M -$9.570M
YoY Change -59.8% -45.56% 118.49%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.480M -$5.208M -$9.564M
YoY Change -59.8% -45.55% 118.36%
Net Earnings / Revenue -5400.0% -3857.78% -2740.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.666M -$1.350M -$3.558M
COMMON SHARES
Basic Shares Outstanding 77.82M shares 77.28M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $48.17M $49.82M $14.82M
YoY Change 208.19% 236.17% 4258.82%
Cash & Equivalents $48.17M $49.82M $14.82M
Short-Term Investments
Other Short-Term Assets $930.0K $620.0K $530.0K
YoY Change 181.82% 16.98% 32.5%
Inventory $63.00K $82.00K $360.0K
Prepaid Expenses
Receivables $160.0K
Other Receivables $0.00
Total Short-Term Assets $49.16M $50.53M $15.87M
YoY Change 204.52% 218.47% 1440.39%
LONG-TERM ASSETS
Property, Plant & Equipment $857.0K $915.0K $714.0K
YoY Change -17.99% 28.15% 155.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $89.00K $92.00K $81.00K
YoY Change -9.18% 13.58% -19.0%
Total Long-Term Assets $1.025M $1.086M $883.0K
YoY Change -16.73% 22.99% 132.37%
TOTAL ASSETS
Total Short-Term Assets $49.16M $50.53M $15.87M
Total Long-Term Assets $1.025M $1.086M $883.0K
Total Assets $50.19M $51.62M $16.75M
YoY Change 188.84% 208.17% 1087.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $326.0K $311.0K $425.0K
YoY Change -49.14% -26.82% -35.61%
Accrued Expenses $822.0K $1.559M $981.0K
YoY Change 5.38% 58.92% 113.26%
Deferred Revenue
YoY Change
Short-Term Debt $380.0K $0.00 $20.62M
YoY Change -100.0% 2845.71%
Long-Term Debt Due $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $1.893M $2.901M $22.04M
YoY Change -77.42% -86.83% 1012.88%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K $20.00K
YoY Change -50.0% -50.0%
Other Long-Term Liabilities $0.00 $10.00K $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $10.00K $20.00K $20.00K
YoY Change -66.67% 0.0% -98.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.893M $2.901M $22.04M
Total Long-Term Liabilities $10.00K $20.00K $20.00K
Total Liabilities $1.902M $2.914M $22.05M
YoY Change -77.37% -86.79% 580.62%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $140.5M $77.00K $59.00K
YoY Change 216049.23% 30.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.28M $48.70M -$5.303M
YoY Change
Total Liabilities & Shareholders Equity $50.19M $51.62M $16.75M
YoY Change 188.84% 208.17% 1087.87%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$6.480M -$5.208M -$9.564M
YoY Change -59.8% -45.55% 118.36%
Depreciation, Depletion And Amortization $100.0K $100.0K $80.00K
YoY Change 25.0% 25.0%
Cash From Operating Activities -$5.400M -$3.900M -$1.980M
YoY Change 95.65% 96.97%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K $20.00K -$100.0K
YoY Change -187.59% -120.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$40.00K $0.00
YoY Change
Cash From Investing Activities -$120.0K -$20.00K -$110.0K
YoY Change -25.0% -81.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.870M 390.0K 9.230M
YoY Change 4.03% -95.77%
NET CHANGE
Cash From Operating Activities -5.400M -3.900M -1.980M
Cash From Investing Activities -120.0K -20.00K -110.0K
Cash From Financing Activities 3.870M 390.0K 9.230M
Net Change In Cash -1.650M -3.530M 7.140M
YoY Change -306.25% -149.44%
FREE CASH FLOW
Cash From Operating Activities -$5.400M -$3.900M -$1.980M
Capital Expenditures -$120.0K $20.00K -$100.0K
Free Cash Flow -$5.280M -$3.920M -$1.880M
YoY Change 82.26% 108.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 onvo Business Acquisition Conversion Ratio
BusinessAcquisitionConversionRatio
0.0001 pure
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
4.50
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77816787 shares
CY2007Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2008Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-96000
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-966000
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2301000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1111295 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
896256 shares
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1835000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1162044 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.48
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2690586 shares
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5303000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14817000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3041476
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
38800
CY2013Q4 onvo Increased Office Space Headquarters
IncreasedOfficeSpaceHeadquarters
15268 sqft
CY2013Q4 onvo Area Of Leased Office Space
AreaOfLeasedOfficeSpace
15539 sqft
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77424956 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1400169 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77424956 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
680742 shares
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11770290 shares
CY2013Q4 us-gaap Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate
0.03 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.62
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4182054 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.95
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1559000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
121000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
134355000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
7331000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
311000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2901000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3473000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
981000
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1006000
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48701000
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
8000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
1004000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1000000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
986000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
766000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
15000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
77000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51615000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2013Q4 us-gaap Liabilities
Liabilities
2914000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
38800
CY2013Q4 us-gaap Assets Current
AssetsCurrent
50529000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
65000
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17375000
CY2013Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2013Q1 us-gaap Liabilities
Liabilities
8406000
CY2013Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
9000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Assets Current
AssetsCurrent
16144000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98000
CY2013Q4 us-gaap Assets
Assets
51615000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49818000
CY2013Q4 us-gaap Grants Receivable
GrantsReceivable
7000
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
82000
CY2013Q4 us-gaap Inventory Net
InventoryNet
82000
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
14259010
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
85731000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
622000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35346304
CY2013Q4 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
79000
CY2013Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
78800
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5241000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
915000
CY2013Q4 onvo Net Rentable Area Expanded
NetRentableAreaExpanded
15268 sqft
CY2007Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10353000
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64686919 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64686919 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
985742 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.11
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3618567 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
780000
CY2013Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75269000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
641000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
8382000
CY2013Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6898000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8969000
CY2013Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15000
CY2013Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6900000
CY2013Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
50000
CY2013Q1 us-gaap Assets
Assets
17375000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15628000
CY2013Q1 us-gaap Grants Receivable
GrantsReceivable
101000
CY2013Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
88000
CY2013Q1 us-gaap Inventory Net
InventoryNet
88000
CY2013Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
66365000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
327000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5909154
CY2013Q1 us-gaap Restricted Cash And Investments
RestrictedCashAndInvestments
88000
CY2013Q1 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
38300
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1045000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25939000
us-gaap Revenues
Revenues
3327000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
280000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
438000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
224000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3000
us-gaap Investment Income Interest
InvestmentIncomeInterest
22000
us-gaap Profit Loss
ProfitLoss
-85731000
us-gaap Revenue From Grants
RevenueFromGrants
993000
us-gaap Operating Income Loss
OperatingIncomeLoss
-31655000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
114000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-162000
us-gaap Interest Paid
InterestPaid
10000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
16000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-54076000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
745000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1077000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27369000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
27369000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
528000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77027000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
134000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4630000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
20000
us-gaap Share Based Compensation
ShareBasedCompensation
5140000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
49818000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1559000
us-gaap Interest Expense
InterestExpense
3484000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
311000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1270000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
32743000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
999000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13502000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
719000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
250000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
438000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1078000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2084000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21346000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
72748000
onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
485000
onvo Convertible Notes Principal Amount
ConvertibleNotesPrincipalAmount
4530000
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
57712000
onvo Fair Value Of Warrant Liabilities In Excess Of Proceeds Received
FairValueOfWarrantLiabilitiesInExcessOfProceedsReceived
19019000
onvo Financing Transaction Costs In Excess Of Proceeds Received
FinancingTransactionCostsInExcessOfProceedsReceived
2130000
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
7000
onvo Interest Accrued On Convertible Notes Payable
InterestAccruedOnConvertibleNotesPayable
495000
onvo Issuance Of Common Stock To Note Holders Shares
IssuanceOfCommonStockToNoteHoldersShares
9202215 shares
onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
725000 shares
onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
77000
onvo Purchased Equipment Through Capital Lease
PurchasedEquipmentThroughCapitalLease
34000
onvo Repayment Of Convertible Notes And Interest Payable
RepaymentOfConvertibleNotesAndInterestPayable
110000
onvo Revenue From Collaborations
RevenueFromCollaborations
2110000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
2653000
onvo Warrants And Related Beneficial Conversion Feature Value
WarrantsAndRelatedBeneficialConversionFeatureValue
824000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-79000
onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
1294
onvo Warrant Issued In Connection With Convertible Notes Payable
WarrantIssuedInConnectionWithConvertibleNotesPayable
1260000
us-gaap Profit Loss
ProfitLoss
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0104 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.908 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
89674 shares
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
13423622 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y15D
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
211250 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45224906 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6137000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
us-gaap Revenues
Revenues
1077000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
36000
us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
us-gaap Profit Loss
ProfitLoss
-6472000
us-gaap Revenue From Grants
RevenueFromGrants
162000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7990000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-158000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1518000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
414000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
351000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3575000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3575000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11002000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-269000
us-gaap Share Based Compensation
ShareBasedCompensation
1431000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4464000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
580000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-401000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
556000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2889000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
178000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
266000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6178000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
10991000
onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
23321000
onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
-3600000
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
162000
onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
onvo Revenue From Collaborations
RevenueFromCollaborations
915000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
-50000
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
13010237 shares
dei Trading Symbol
TradingSymbol
ONVO
dei Entity Registrant Name
EntityRegistrantName
ORGANOVO HOLDINGS, INC.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001497253
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
60000 shares
us-gaap Revenue Recognition Multiple Element Arrangements
RevenueRecognitionMultipleElementArrangements
<div> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"> Revenue Arrangements with Multiple Deliverables</p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"> The Company occasionally enters into revenue arrangements that contain multiple deliverables. Judgment is required to properly identify the accounting units of the multiple deliverable transactions and to determine the manner in which revenue should be allocated among the accounting units. Moreover, judgment is used in interpreting the commercial terms and determining when all criteria of revenue recognition have been met for each deliverable in order for revenue recognition to occur in the appropriate accounting period. For multiple deliverable agreements, consideration is allocated at the inception of the agreement to all deliverables based on their relative selling price. The relative selling price for each deliverable is determined using vendor-specific objective evidence (&#x201C;VSOE&#x201D;) of selling price or third-party evidence of selling price if VSOE does not exist. If neither VSOE nor third-party evidence of selling price exists, the Company uses its best estimate of the selling price for the deliverable.</p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"> The Company recognizes revenue for delivered elements only when it determines there are no uncertainties regarding customer acceptance. While changes in the allocation of the arrangement consideration between the units of accounting will not affect the amount of total revenue recognized for a particular sales arrangement, any material changes in these allocations could impact the timing of revenue recognition, which could affect the Company&#x2019;s results of operations.</p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"> The Company expects to periodically receive license fees for non-exclusive research licensing associated with funded research projects. License fees under these arrangements are recognized over the term of the contract or development period as it has been determined that such licenses do not have stand-alone value.</p> </div>
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> Product Revenue</p> <p style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"> The Company recognizes product revenue at the time of shipment to the customer, provided all other revenue recognition criteria have been met. The Company recognizes product revenues upon shipment to distributors, provided that (i)&#xA0;the price is substantially fixed or determinable at the time of sale; (ii)&#xA0;the distributor&#x2019;s obligation to pay the Company is not contingent upon resale of the products; (iii)&#xA0;title and risk of loss passes to the distributor at the time of shipment; (iv)&#xA0;the distributor has economic substance apart from that provided by the Company; (v)&#xA0;the Company has no significant obligation to the distributor to bring about the resale of the products; and (vi)&#xA0;future returns can be reasonably estimated. For any sales that do not meet all of the above criteria, revenue is deferred until all such criteria have been met.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0082 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.839 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
164243 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y8M12D
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
2404519 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
305000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y6M
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
83801 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.31
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71606724 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.32
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
The estimated useful lives of the fixed assets range between two and five years.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10161000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.33
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
665743 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
18455 shares
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-4000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
7000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5403000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-6000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <i>Use of estimates</i></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. Significant estimates used in preparing the condensed consolidated financial statements include those assumed in computing the valuation of warrants, revenue recognized under the proportional performance model, the valuation of stock-based compensation expense, and the valuation allowance on deferred tax assets.</p> </div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
365000 shares
us-gaap Revenues
Revenues
264000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
452000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
195000
us-gaap Investment Income Interest
InvestmentIncomeInterest
11000
us-gaap Profit Loss
ProfitLoss
-19366000
us-gaap Revenue From Grants
RevenueFromGrants
50000
us-gaap Operating Income Loss
OperatingIncomeLoss
-13963000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-5397000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
5397000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
156000
us-gaap Dilutive Securities
DilutiveSecurities
0
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2840000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44498000
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-42000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
732521
us-gaap Share Based Compensation
ShareBasedCompensation
2840000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34190000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
779000
us-gaap Interest Expense
InterestExpense
13000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-330000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-147000
us-gaap Cost Of Services Amortization
CostOfServicesAmortization
182000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5420000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
195000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
288000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
322000
us-gaap Restructuring Costs
RestructuringCosts
2100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8807000
onvo Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
44310000
onvo Stock Issued During Period Value Public Offering
StockIssuedDuringPeriodValuePublicOffering
43375000
onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
10522000
onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
5400000
onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
12000
onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
10522000
onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
767000
onvo Companys Stockholders Retained Voting Interest
CompanysStockholdersRetainedVotingInterest
0.25 pure
onvo Deduction In Warrant Liability
DeductionInWarrantLiability
10522000
onvo Fee For Additional Research And Development Services
FeeForAdditionalResearchAndDevelopmentServices
135000
onvo Former Security Holders Common Stock Voting Interest
FormerSecurityHoldersCommonStockVotingInterest
0.75 pure
onvo Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-94000
onvo Issued Warrants To Purchase Share Of Common Stock For Consulting Services Shares
IssuedWarrantsToPurchaseShareOfCommonStockForConsultingServicesShares
75000 shares
onvo Lease Term With Option To Extend
LeaseTermWithOptionToExtend
P48M
onvo Payment For Expense On Warrant Modification
PaymentForExpenseOnWarrantModification
12000
onvo Research And Development Services Contract Value
ResearchAndDevelopmentServicesContractValue
1500000
onvo Revenue From Collaborations
RevenueFromCollaborations
214000
onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
935000
onvo Warrant Reclassified Equity Instruments
WarrantReclassifiedEquityInstruments
767000
onvo Increase Decrease In Cash Deposits Released From Restriction
IncreaseDecreaseInCashDepositsReleasedFromRestriction
9000
onvo Issued Warrants To Purchase Shares Of Common Stock Or Consulting Services
IssuedWarrantsToPurchaseSharesOfCommonStockOrConsultingServices
404
onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
1878104 shares
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10350000 shares
CY2013Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43400000
CY2009 us-gaap Profit Loss
ProfitLoss
-872000
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2010 us-gaap Profit Loss
ProfitLoss
-1339000
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000
CY2011 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1111000
CY2011 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
239000
CY2011 us-gaap Profit Loss
ProfitLoss
-4383000
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3490000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9000
CY2008 us-gaap Profit Loss
ProfitLoss
-98000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1380000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.95
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.08
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2023394 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5000 shares
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
224064 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.25
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1143735 shares
CY2012 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
890000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000
CY2012 us-gaap Profit Loss
ProfitLoss
-43553000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1435000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
564641
CY2012 onvo Adjustments To Additional Paid In Capital Loss On Inducement To Exercise Warrants
AdjustmentsToAdditionalPaidInCapitalLossOnInducementToExerciseWarrants
1904000
CY2012 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23321000
CY2012 onvo Costs Associated With Merger
CostsAssociatedWithMerger
13723000
CY2012 onvo Duration After Which Warrants Are Exercisable
DurationAfterWhichWarrantsAreExercisable
P5Y
CY2012 onvo Issuance Of Common Stock Through Conversion Of Notes Payable And Accrued Interest In Connection With Merger
IssuanceOfCommonStockThroughConversionOfNotesPayableAndAccruedInterestInConnectionWithMerger
1526000
CY2012 onvo Issuance Of Common Stock Through Private Placements In Connection With Merger
IssuanceOfCommonStockThroughPrivatePlacementsInConnectionWithMerger
13723000
CY2012 onvo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndExpirationsInPeriod
185516 shares
CY2012 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
10991000
CY2012 onvo Number Of Offerings Under Private Placement Reverse Merger
NumberOfOfferingsUnderPrivatePlacementReverseMerger
3 Private_placement
CY2012Q1 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
1 for 1 basis
CY2012Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1500000
CY2012Q1 onvo Accrued Interest On Convertible Notes
AccruedInterestOnConvertibleNotes
25387
CY2013Q4 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2014-09-01
CY2013Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2016-08-01
CY2013Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
38934
CY2013Q4 onvo Additional Office Space
AdditionalOfficeSpace
14500 sqft
CY2013Q4 onvo Office Space Area Under Lease Agreement
OfficeSpaceAreaUnderLeaseAgreement
30807 sqft
CY2011Q4 onvo Duration After Which Warrants Are Exercisable
DurationAfterWhichWarrantsAreExercisable
P5Y
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
55000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.93
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
927981 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
196612 shares
CY2013Q1 us-gaap Profit Loss
ProfitLoss
-16120000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
848000
CY2013Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
CY2013Q1 onvo Adjustments To Additional Paid In Capital Expense On Modification Of Warrant
AdjustmentsToAdditionalPaidInCapitalExpenseOnModificationOfWarrant
65000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability From Exercises Of Warrants
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityFromExercisesOfWarrants
23869000
CY2013Q1 onvo Adjustments To Additional Paid In Capital Warrant Liability Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalWarrantLiabilityReclassifiedToEquity
1886000
CY2013Q1 onvo Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedAndExpirationsInPeriod
34690 shares
CY2013Q1 onvo Stockholders Equity During Period Value Issuance Of Common Stock From Warrant Exercises
StockholdersEquityDuringPeriodValueIssuanceOfCommonStockFromWarrantExercises
3724000
CY2012Q4 onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
4800000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0089 pure
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.962 pure
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
9021 shares
CY2012Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11612791 shares
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y18D
CY2012Q4 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
21250 shares
CY2012Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48428186 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.39
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2012Q4 us-gaap Revenues
Revenues
349000
CY2012Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2012Q4 us-gaap Profit Loss
ProfitLoss
-9564000
CY2012Q4 us-gaap Revenue From Grants
RevenueFromGrants
67000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2922000
CY2012Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6642000
CY2012Q4 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2012Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4740000
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1130000
CY2012Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
109000
CY2012Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2141000
CY2012Q4 onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
19593000
CY2012Q4 onvo Loss On Inducement To Exercise
LossOnInducementToExercise
1904000
CY2012Q4 onvo Revenue From Collaborations
RevenueFromCollaborations
282000
CY2012Q4 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
11241762 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0078 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.823 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
3703 shares
CY2013Q4 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
533533 shares
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2013Q4 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
8750 shares
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
77235976 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.54
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2013Q4 us-gaap Revenues
Revenues
135000
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
CY2013Q4 us-gaap Profit Loss
ProfitLoss
-5208000
CY2013Q4 us-gaap Revenue From Grants
RevenueFromGrants
38000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-4626000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582000
CY2013Q4 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
586000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2359000
CY2013Q4 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
112000
CY2013Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2402000
CY2013Q4 onvo Decrease In Warrant Liability
DecreaseInWarrantLiability
375000
CY2013Q4 onvo Changes In Fair Value Of Derivative Liability
ChangesInFairValueOfDerivativeLiability
600000
CY2013Q4 onvo Fee For Additional Research And Development Services
FeeForAdditionalResearchAndDevelopmentServices
135000
CY2013Q4 onvo Research And Development Services Contract Value
ResearchAndDevelopmentServicesContractValue
1500000
CY2013Q4 onvo Revenue From Collaborations
RevenueFromCollaborations
97000
CY2013Q4 onvo Number Of Warrant Exercised During Period Recorded As Derivative Liability
NumberOfWarrantExercisedDuringPeriodRecordedAsDerivativeLiability
60176 shares

Files In Submission

Name View Source Status
0001193125-14-038955-index-headers.html Edgar Link pending
0001193125-14-038955-index.html Edgar Link pending
0001193125-14-038955.txt Edgar Link pending
0001193125-14-038955-xbrl.zip Edgar Link pending
d652846d10q.htm Edgar Link pending
d652846dex102.htm Edgar Link pending
d652846dex103.htm Edgar Link pending
d652846dex104.htm Edgar Link pending
d652846dex105.htm Edgar Link pending
d652846dex106.htm Edgar Link pending
d652846dex311.htm Edgar Link pending
d652846dex312.htm Edgar Link pending
d652846dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g652846g77f09.jpg Edgar Link pending
onvo-20131231.xml Edgar Link completed
onvo-20131231.xsd Edgar Link pending
onvo-20131231_cal.xml Edgar Link unprocessable
onvo-20131231_def.xml Edgar Link unprocessable
onvo-20131231_lab.xml Edgar Link unprocessable
onvo-20131231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending